Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_assertion type Assertion NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_head.
- NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_assertion description "[These regions harbor established oncogenes and tumor suppressors, including CCND1 (cyclin D1), MET (hepatocyte growth factor receptor), CDKN2A (cyclin-dependent kinase inhibitor 2A) and CDKN2B (cyclin-dependent kinase inhibitor 2B), as well as many other genes not previously reported to be involved in liver carcinogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_provenance.
- NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_assertion evidence source_evidence_literature NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_provenance.
- NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_assertion SIO_000772 23505090 NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_provenance.
- NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_assertion wasDerivedFrom befree-20150227 NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_provenance.
- NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_assertion wasGeneratedBy ECO_0000203 NP261544.RAXnXehUZ-GAQ9PSC0AmVtNZDfPifbRvjlpzbLYArSG1E130_provenance.